Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatocyte-specific Pten deficient mice].

Yasuo Horie1, Shigetoshi Ohshima, Wataru Sato

  • 1Division of Gastroenterology, Department of Internal Medicine, Akita University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Niche-targeted therapy via YAP/TAZ activation enhances hematopoietic regeneration.

Blood·2026
Same author

SAMD4 represses VGLL4 mRNA to activate TEAD and promote cancer progression.

Oncogene·2026
Same author

Jean-François Morot-Gaudry (1943-2024): A Life Devoted to Plant Science, Leadership, and Humanity.

Plants (Basel, Switzerland)·2025
Same author

PTEN regulates vagal-insulin signaling to optimize autonomic output determining peripheral inflammatory and metabolic homeostasis.

Nature communications·2025
Same author

Domain-adaptive semi-supervised learning for efficient rare pathological lesion detection with minimal annotation.

NPJ digital medicine·2025
Same author

Adrenal lipoma formation via PI(3,4,5)P<sub>3</sub>/AKT-dependent transdifferentiation of adrenocortical cells into adipocytes.

Proceedings of the National Academy of Sciences of the United States of America·2025

Hepatocyte-specific Pten deficient mice serve as a powerful model for nonalcoholic steatohepatitis (NASH). These mice develop NASH pathology, offering insights into human disease mechanisms and potential therapies.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Oncology

Background:

  • Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with limited therapeutic options.
  • Hepatocyte-specific Pten deficiency leads to histological findings consistent with human NASH.
  • Pten-deficient mice represent a valuable model for studying NASH pathogenesis.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying NASH development in Pten-deficient mice.
  • To explore the role of Pten deficiency in steatosis, inflammation, and hepatocellular carcinoma progression.
  • To identify potential therapeutic targets for NASH.

Main Methods:

  • Histological analysis of liver tissues from Pten-deficient mice.
  • Gene expression profiling to identify key molecular pathways.

Related Experiment Videos

  • Assessment of oxidative stress markers and DNA damage.
  • Evaluation of hepatocyte proliferation and malignant potential.

    • Main Results:

    • Pten deficiency induced steatosis via increased fatty acid synthesis gene expression.
    • Upregulation of beta-oxidation genes led to oxidative stress and hepatitis.
    • Intestinal bacterial endotoxins exacerbated hepatitis.
    • Akt and ERK activation promoted hepatocyte proliferation and malignant potential.

    Conclusions:

    • Pten-deficient mice recapitulate key features of human NASH, including steatosis, hepatitis, and hepatocellular carcinoma.
    • The study elucidates the pathogenesis of NASH, involving lipid metabolism, oxidative stress, inflammation, and genetic factors.
    • Findings provide a foundation for developing novel therapeutic strategies for NASH.